A. Elias

Treatment Efficacy Score - continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

L. Pusztai, D. Yee, C. Yau, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of panobinostat (LBH589) in combination with trastuzumab in pretreated HER2-positive metastatic breast cancer (mBC): Preliminary safety and tolerability results.

D. Amadori, F. Schuetz, M. Campone, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.

C. Shapiro, G. Demetri, R. Gelman, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract P5-05-05: Targeting the androgen receptor with seviteronel, a CYP17 lyase and AR inhibitor, in triple negative breast cancer

Jason Gertz, Jessica L. Christenson, N. Spoelstra, 2019, Poster Session Abstracts.